The School for Oncology & Developmental Biology (GROW) focuses on research and teaching of genetic and cellular mechanisms, as well as environmental and life-style factors that underlie normal (embryonic and fetal) and abnormal (cancer) development. The emphasis is on basic and translational research, aiming at innovative approaches for individualizing prevention, patient diagnosis, and treatment for genetically determined diseases and cancer.
GROW research activities in the areas of oncology and developmental medicine are closely interrelated, revolving around the same basic concepts and research techniques. Scientists at GROW collaborate intensively with clinicians at the Maastricht Oncology Centre and the Centre for Genetics, Reproduction and Child Health.
An important aim within GROW is training master's and PhD students in the fields of modern medicine and molecular life sciences.
“Our results have been a wake-up call for IVF centers worldwide.”
“Ultimately, we want personal, tailor-made lifestyle advice for every cancer survivor who needs it.”
“We are repurposing a well-known malaria-drug for our fight against cancer.”
This year, for the first time, two TEFAF Fellowships are awarded to PhD students from GROW (School for Oncology & Developmental Biology). Femke Ehlers and Nicky Beelen will have the opportunity to perform part of their research in the renowned lab of the TEFAF Honorary Chair, Professor Dr. Lisa Coussens at Oregon Health and Science Knight Cancer Center.
How can you further improve healthcare with the use of ‘big data’? That question is central to many scientific studies worldwide. Last month, two PhD candidates at Maastricht University defended their theses based on this same key question.
GROW works in close cooperation with the Maastricht University Medical Center+ (MUMC+). MUMC+ is known both nationally and internationally for its focus on prevention and taking an integrated approach to health care: from prevention, promotion of good health, and basic care, to top-level clinical diagnostics and treatment. Patient safety is our top priority in all of our endeavours. MUMC+ is part of The Netherlands Federation of University Medical Centres.